Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Membership

Publications

ESC Working Group on Thrombosis

The Working Group on Thrombosis is involved in many scientific publications

Consensus and Position Papers

The Working Group writes article in the ESC Journal Family and especially in the Cardiovascular Research journal and European Heart Journal

ESC Clinical Practice Guidelines

Access Guidelines >

Paper of the Month

Access Papers of the Month >

ESC Journals

Access the Cardiovascular Research journal

Access the European Heart Journal

Thrombosis and Haemostasis Journal

Thrombosis and Haemostasis publishes original articles with a broad scope in basic research and clinical studies in vascular biology and medicine. It is published monthly in print (ISSN 0340-6245) and online.

The journal’s contribution to advancing the field of haematology is the reason why it is read by haematologists, clinical pharmacologists, cardiologists, surgeons, internal specialists and laboratory physicians.

http://www.thrombosis-online.com/

Recommended Reading

Date

Title

Date: 2024

Title: Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 h
Date: 2024

Title: Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials
Date: 2024

Title: Characteristics and outcomes in patients with a prior myocardial infarction treated with extended dual antiplatelet therapy with ticagrelor 60 mg: findings from ALETHEIA, a multi-country observational study
Date: 2024

Title: Platelet biology and function: plaque erosion vs. rupture
Date: 2024

Title: Inflammation in acute myocardial infarction: the good, the bad and the ugly
Date: 2023

Title: Factor XIa inhibitors: collecting the clinical evidence
Date: 2023

Title: Anticoagulation with edoxaban in patients with long Atrial High-Rate Episodes ≥24 hours
Date: 2023

Title: Pharmacology and Clinical Development of Factor XI Inhibitors
Date: 2023

Title: Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a Fracture
Date: 2023

Title: Safety and efficacy of very low LDL-cholesterol intensive lowering: a meta-analysis and meta-regression of randomized trials
Date: 2023

Title: Clinical Evaluation of Factor XIa Inhibitor Drugs: JACC Review Topic of the Week
Date: 2023

Title: Risk factors profile of young and older patients with myocardial infarction
Date: 2023

Title: Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54
Date: 2023

Title: Apixaban for patients with atrial fibrillation on hemodialysis: a multicenter randomized controlled trial
Date: 2022

Title: Prognostic implications of neutrophil extracellular traps in coronary thrombi of patients with st-elevation myocardial infarction
Date: 2022

Title: Neutrophil extracellular traps in the infarct-related coronary artery—a marker or mediator of adverse outcome?
Date: 2022

Title: Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial
Date: 2021

Title: 2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary
Date: 2021

Title: 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
Date: 2021

Title: Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
Date: 2021

Title: Severe SARS-CoV-2 infection inhibits fibrinolysis leading to changes in viscoelastic properties of blood clot: A descriptive study of fibrinolysis
Date: 2021

Title: Antibody-induced procoagulant platelets in severe COVID-19 infection
Date: 2021

Title: Genetic Risk Score to Identify Risk of Venous Thromboembolism in Patients With Cardiometabolic Disease
Date: 2021

Title: Assessing the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After Coronary Stent Implantation: The ARC-High Bleeding Risk Trade-off Model
Date: 2021

Title: COVID-19-related medical research: a meta-research and critical appraisal
Date: 2020

Title: Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve
Date: 2020

Title: Characteristics and Strength of Evidence of COVID-19 Studies Registered on ClinicalTrials.gov
Date: 2020

Title: Antithrombotic Therapy for Patients with Left Ventricular Mural Thrombus
Date: 2019

Title: Thrombogenicity and Antithrombotic Strategies in Structural Heart Interventions and Nonaortic Cardiac Device Therapy-Current Evidence and Practice
Date: 2019

Title: Activated platelets promote an osteogenic programme and the progression of calcific aortic valve stenosis
Date: 2019

Title: Antithrombotic therapy in patients undergoing transcatheter aortic valve implantation
Date: 2019

Title: Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer
Date: 2019

Title: A changing landscape: Temporal trends in incidence and characteristics of patients hospitalized with venous thromboembolism 2006-2015
Date: 2019

Title: Diurnal Variability of On-Treatment Platelet Reactivity in Clopidogrel versus Prasugrel Treated Acute Coronary Syndrome Patients: A Pre-Specified TROPICAL-ACS Sub-Study
Date: 2019

Title: Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
Date: 2019

Title: Staphylococcus aureus endocarditis: distinct mechanisms of bacterial adhesion to damaged and inflamed heart valves
Date: 2019

Title: Contractile forces in platelet aggregates under microfluidic shear gradients reflect platelet inhibition and bleeding risk
Date: 2019

Title: Admission Levels of DKK1 (Dickkopf-1) Are Associated With Future Cardiovascular Death in Patients With Acute Coronary Syndromes
Date: 2019

Title: Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study